Ancestral Mutation in Telomerase Causes Defects in Repeat Addition Processivity and Manifests As Familial Pulmonary Fibrosis
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The telomerase reverse transcriptase synthesizes new telomeres onto chromosome ends by copying from a short template within its integral RNA component. During telomere synthesis, telomerase adds multiple short DNA repeats successively, a property known as repeat addition processivity. However, the consequences of defects in processivity on telomere length maintenance are not fully known. Germline mutations in telomerase cause haploinsufficiency in syndromes of telomere shortening, which most commonly manifest in the age-related disease idiopathic pulmonary fibrosis. We identified two pulmonary fibrosis families that share two non-synonymous substitutions in the catalytic domain of the telomerase reverse transcriptase gene hTERT: V791I and V867M. The two variants fell on the same hTERT allele and were associated with telomere shortening. Genealogy suggested that the pedigrees shared a single ancestor from the nineteenth century, and genetic studies confirmed the two families had a common founder. Functional studies indicated that, although the double mutant did not dramatically affect first repeat addition, hTERT V791I-V867M showed severe defects in telomere repeat addition processivity in vitro. Our data identify an ancestral mutation in telomerase with a novel loss-of-function mechanism. They indicate that telomere repeat addition processivity is a critical determinant of telomere length and telomere-mediated disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
From The telomere syndromes (2012) · cites this paper as [76]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“Telomerase is a specialized DNA polymerase that synthesizes new telomere repeats onto chromosome ends [1,2].”
BackgroundMerlin—rapid analysis of dense genetic maps using sparse gene flow trees
Abecasis, G. R., Cherny, S. S., Cookson, W. O., & Cardon, L. R. (2002) · Nature Genetics · doi:10.1038/ng786 · Cited by 3,354 · cited 1×
“We used Merlin to calculate a single point LOD score [44], under the assumption of autosomal dominant inheritance and a 1/10,000 population frequency of idiopathic interstitial lung disease.”
MethodThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“Telomerase has two essential conserved components, a catalytic reverse transcriptase, hTERT, and an RNA component, hTR [3,4].”
BackgroundA telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · cited 1×
“The RNA component of telomerase contains a template sequence for the addition of new telomere repeats [5].”
BackgroundObesity, cigarette smoking, and telomere length in women
Valdes, A., Andrew, T., Gardner, J., Kimura, M., Oelsner, E., Cherkas, L., Aviv, A., & Spector, T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66630-5 · Cited by 1,363 · cited 1×
“risk of both emphysema and pulmonary fibrosis [39], it is”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 10×
“At standard assay conditions of 1 mM nucleotide concentrations [8,12,13,20,27], the 791I alone did not have obvious defects in activity or processivity (Figure 3A, lane 3).”
BackgroundMethodInfluentialSelf-citationReverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269 · cited 2×
“Telomerase has two essential conserved components, a catalytic reverse transcriptase, hTERT, and an RNA component, hTR [3,4].”
BackgroundHemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219 · cited 1×
“Telomerase preferentially elongates the shortest telomeres [41,42], and our functional studies which show intact single repeat synthesis, point to the fact that the ancestral hTERT 791I-867M may have the capacity to add initial telomere tracts, thus healing the shortest telomeres.”
BackgroundGreider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150 · cited 1×
“Telomerase is a specialized DNA polymerase that synthesizes new telomere repeats onto chromosome ends [1,2].”
BackgroundThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 2×
“Several mechanisms of telomerase haploinsufficiency have been previously reported for disease causing mutations including loss of hTR stability, impaired association of hTR with hTERT, and loss of catalytic function [13,20,22,24,25].”
BackgroundAdult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · cited 1×
“Mutations in hTERT or hTR underlie the inheritance in 8–15% of familial forms of pulmonary fibrosis and 1–3% of sporadic cases [12–15].”
BackgroundShort telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805 · cited 4×
“A subset of pulmonary fibrosis patients and families with short telomeres suffer complications from aplastic anemia and cryptogenic liver cirrhosis [12,13,20,21].”
BackgroundMethodInfluentialSelf-citationMutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723 · cited 1×
“The single nucleotide variants were absent in 200 ethnically matched controls, as well as in a multi-ethnic control panel examining the hTERT gene sequence [23].”
BackgroundSelf-citationThe POT1-TPP1 telomere complex is a telomerase processivity factor.
Wang, F., Podell, E. R., Zaug, A. J., Yang, Y., Baciu, P., Cech, T. R., & Lei, M. (2007) · Nature · doi:10.1038/nature05454 · Cited by 704 · cited 1×
“first repeat, and plotted against the repeat number [9].”
BackgroundTelomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573 · cited 1×
“Mutations in hTERT or hTR underlie the inheritance in 8–15% of familial forms of pulmonary fibrosis and 1–3% of sporadic cases [12–15].”
BackgroundTeixeira, M. T., Arneric, M., Sperisen, P., & Lingner, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00334-4 · Cited by 526 · cited 1×
“Telomerase preferentially elongates the shortest telomeres [41,42], and our functional studies which show intact single repeat synthesis, point to the fact that the ancestral hTERT 791I-867M may have the capacity to add initial telomere tracts, thus healing the shortest telomeres.”
BackgroundThe Structure and Function of Telomerase Reverse Transcriptase
Autexier, C., & Lue, N. F. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142412 · Cited by 489 · cited 1×
“In order to synthesize long telomere tracts, hTERT copies from the RNA template once, translocates, and then iteratively adds successive repeats [6].”
BackgroundCancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood · doi:10.1182/blood-2008-12-192880 · Cited by 478 · cited 9×
“One individual had avascular necrosis and macrocytosis, two individuals reported history of cryptogenic liver function abnormalities, and one patient had a history of AML prior to the diagnosis of interstitial lung disease.”
BackgroundInfluentialArmanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452 · cited 6×
“Telomerase haploinsufficiency causes telomere shortening and the severity of the consequent phenotypes correlates with the telomere length [20,34].”
BackgroundMethodInfluentialSelf-citationTelomere length is paternally inherited and is associated with parental lifespan
Njajou, O. T., Cawthon, R. M., Damcott, C. M., Wu, S.-H., Ott, S., Garant, M. J., Blackburn, E. H., Mitchell, B. D., Shuldiner, A. R., & Hsueh, W.-C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702703104 · Cited by 387 · cited 1×
“determines offspring telomere length even when telomerase is wildtype [34,36,37].”
BackgroundTelomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010680 · Cited by 377
Alter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356 · cited 1×
“In 6 of 9 mutation carriers, the telomere length fell below the 1 percentile, a range that is highly specific for the presence of a germline telomere maintenance defect [12,13,35] (Figure 4, P,0.”
BackgroundSelf-citationSyndromes of Telomere Shortening
Armanios, M. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150046 · Cited by 317 · cited 6×
“In the majority of cases (7 of 11, 64%), the interstitial lung disease met the criteria for usual interstitial pneumonia/IPF (Figure 5A, 5B and Table S1).”
BackgroundInfluentialSelf-citationShort Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302 · cited 2×
“Telomerase haploinsufficiency causes telomere shortening and the severity of the consequent phenotypes correlates with the telomere length [20,34].”
BackgroundSelf-citationShort Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
Armanios, M., Alder, J. K., Parry, E. M., Karim, B., Strong, M. A., & Greider, C. W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.028 · Cited by 257 · cited 1×
“determines offspring telomere length even when telomerase is wildtype [34,36,37].”
BackgroundSelf-citationGreider, C. W. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4572 · Cited by 238 · cited 1×
“This property is known as telomere repeat addition processivity [7].”
BackgroundDyskeratosis congenita: a genetic disorder of many faces
Kirwan, M., & Dokal, I. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00923.x · Cited by 236 · cited 10×
“Bone marrow failure, avascular necrosis and cryptogenic liver cirrhosis are all known complications of dyskeratosis congenita [17], and pulmonary fibrosis families with mutant telomerase genes have been known to have an increased incidence of aplastic anemia, a common complication of dyskeratosis congenita [13].”
BackgroundInfluentialPodlevsky, J. D., Bley, C. J., Omana, R. V., Qi, X., & Chen, J. J.-L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm700 · Cited by 233
Self-citationConstitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Calado, R. T., Regal, J. A., Hills, M., Yewdell, W. T., Dalmazzo, L. F., Zago, M. A., Lansdorp, P. M., Hogge, D., Chanock, S. J., Estey, E. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807057106 · Cited by 184 · cited 2×
“AML, both de novo, and in the setting of myelodysplasia, has also been reported as a first manifestation of germline mutant telomerase genes [18,19].”
BackgroundSelf-citationChen, J. J. ‐., & Greider, C. W. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg024 · Cited by 147 · cited 1×
“At standard assay conditions of 1 mM nucleotide concentrations [8,12,13,20,27], the 791I alone did not have obvious defects in activity or processivity (Figure 3A, lane 3).”
MethodSelf-citationNuclear and Cytoplasmic Pools of Deoxyribonucleoside Triphosphates in Chinese Hamster Ovary Cells
Skoog, L., & Bjursell, G. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)42175-3 · Cited by 141 · cited 1×
“The lower concentrations also more closely mimic estimates of intra-nuclear nucleotide concentrations (10 mM) [31–33].”
BackgroundDevelopment and aging of primitive hematopoietic stem cells in BALB/cBy mice
Chen, J., Astle, C. M., & Harrison, D. E. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00018-1 · Cited by 109 · cited 1×
“At standard assay conditions of 1 mM nucleotide concentrations [8,12,13,20,27], the 791I alone did not have obvious defects in activity or processivity (Figure 3A, lane 3).”
MethodSelf-citationKirwan, M., Vulliamy, T., Marrone, A., Walne, A. J., Beswick, R., Hillmen, P., Kelly, R., Stewart, A., Bowen, D., Schonland, S. O., et al. (2009) · Human Mutation · doi:10.1002/humu.21115 · Cited by 109 · cited 2×
“AML, both de novo, and in the setting of myelodysplasia, has also been reported as a first manifestation of germline mutant telomerase genes [18,19].”
BackgroundThe effect of TERC haploinsufficiency on the inheritance of telomere length
Goldman, F., Bouarich, R., Kulkarni, S., Freeman, S., Du, H.-Y., Harrington, L., Mason, P. J., Londoño-Vallejo, A., & Bessler, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505318102 · Cited by 106 · cited 1×
“In a large dyskeratosis congenita family, siblings of mutation carriers were shown to have short telomeres; however telomere-related phenotypes in these individuals have not been previously reported [38].”
BackgroundA Mutant of Tetrahymena Telomerase Reverse Transcriptase with Increased Processivity
Bryan, T. M., Goodrich, K. J., & Cech, T. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003246200 · Cited by 100 · cited 1×
“Studies of the Tetrahymena thermophila TERT have also implicated the orthologous residue adjacent to V867 in repeat addition processivity [40].”
BackgroundLue, N. F., Lin, Y.-C., & Mian, S. I. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8440-8449.2003 · Cited by 94 · cited 1×
“hTERT V791 fell within the insertion in finger domain (IFD) between the A and B motifs of the reverse transcriptase domain [10,26], a telomerase specific motif (Figure 1B, 1C).”
BackgroundRobart, A. R., & Collins, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088575 · Cited by 89
Functional characterization of telomerase RNA variants found in patients with hematologic disorders
Ly, H., Calado, R. T., Allard, P., Baerlocher, G. M., Lansdorp, P. M., Young, N. S., & Parslow, T. G. (2005) · Blood · doi:10.1182/blood-2004-09-3659 · Cited by 85 · cited 2×
“Several mechanisms of telomerase haploinsufficiency have been previously reported for disease causing mutations including loss of hTR stability, impaired association of hTR with hTERT, and loss of catalytic function [13,20,22,24,25].”
BackgroundSelf-citationLeem, S., Londoño‐Vallejo, A., Kim, J.-H., Bui, H., Tubacher, E., Solomon, G. G., Park, J., Horikawa, I., Kouprina, N., Barrett, J. C., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205122 · Cited by 85 · cited 1×
“We amplified and genotyped mini-satellites/variable number of tandem repeats within hTERT: 2–2 (intron 2) and 6–1 (intron 6) as published [45].”
MethodXie, M., Podlevsky, J. D., Qi, X., Bley, C. J., & Chen, J. J. ‐. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1198 · Cited by 78
Self-citationThe K65R Mutation Confers Increased DNA Polymerase Processivity to HIV-1 Reverse Transcriptase
Arion, D., Borkow, G., Gu, Z., Wainberg, M. A., & Parniak, M. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19860 · Cited by 53 · cited 1×
“The lower concentrations also more closely mimic estimates of intra-nuclear nucleotide concentrations (10 mM) [31–33].”
BackgroundEffect of dGTP Concentration on Human and CHO Telomerase
Maine, I. P., Chen, S.-F., & Windle, B. E. (1999) · Biochemistry · doi:10.1021/bi991596+ · Cited by 47 · cited 1×
“Since the segregation and the genetic evidence supported the 791I867M being a pathogenic allele, we assayed its function at nucleotide concentrations that are closer to the estimated Km for telomerase [29,30].”
BackgroundDrosopoulos, W. C., & Prasad, V. R. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm002 · Cited by 30 · cited 1×
“Single nucleotide titration studies have implicated hTERT V867 to be important in telomerase function [28].”
BackgroundNontemplated Nucleotide Addition by HIV-1 Reverse Transcriptase
Golinelli‐Cohen, M., & Hughes, S. H. (2002) · Biochemistry · doi:10.1021/bi0160415 · Cited by 29 · cited 1×
“The lower concentrations also more closely mimic estimates of intra-nuclear nucleotide concentrations (10 mM) [31–33].”
BackgroundJarstfer, M. B., & Cech, T. R. (2001) · Biochemistry · doi:10.1021/bi011649z · Cited by 27 · cited 1×
“Since the segregation and the genetic evidence supported the 791I867M being a pathogenic allele, we assayed its function at nucleotide concentrations that are closer to the estimated Km for telomerase [29,30].”
Background
Cited by
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982
Self-citationTelomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 347
“IPF presents at a mean age between 50 and 60 years (range 31–87) (35, 45, 47, 51, 59, 60), and telomere-related cryptogenic liver fibrosis, based on reported cases, presents at a mean of 37 years (range 20–57) (12, 59, 61).”
Self-citationBone marrow failure and the telomeropathies
Townsley, D. M., Dumitriu, B., & Young, N. S. (2014) · Blood · doi:10.1182/blood-2014-05-526285 · Cited by 291
Diagnostic utility of telomere length testing in a hospital-based setting
Alder, J. K., Hanumanthu, V. S., Strong, M. A., DeZern, A. E., Stanley, S. E., Takemoto, C. M., Danilova, L., Applegate, C. D., Bolton, S. G., Mohr, D. W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720427115 · Cited by 268
Self-citationTelomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265
Self-citation
Metadata
- Authors
- Alder, J. K., Cogan, J. D., Brown, A. F., Anderson, C. J., Lawson, W. E., Lansdorp, P. M., Phillips, J. A., Loyd, J. E., Chen, J. J.-L., & Armanios, M.
- Affiliations
- Johns Hopkins University (US)
- Vanderbilt University (US)
- Arizona State University (US)
- University of British Columbia (CA)
- Corresponding author
- Armanios, Mary
- ORCID
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-03-31
- Volume
- 7
- Issue
- 3
- Pages
- e1001352
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3069110
- OpenAlex
- W2080657387
- Cited by
- 119
- References
- 46
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 7 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 4 · 2014: 12 · 2013: 9 · 2012: 8
- FWCI
- 7.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, other-oa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Science Foundation (0642857, CAREER)
- Doris Duke Charitable Foundation
- Vanderbilt University
- National Institutes of Health (HL092870)
- National Heart, Lung, and Blood Institute (K08HL085406, P01HL092870, T32HL094296)
- National Cancer Institute (K08CA118416, KO8 CA118416)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Keywords
- telomerase reverse transcriptase, hTERT, telomere maintenance, idiopathic pulmonary fibrosis, familial pulmonary fibrosis, germline mutations, founder mutation, haploinsufficiency, telomere shortening, loss-of-function mechanism, catalytic domain
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mutation, Pedigree, Pulmonary Fibrosis, Telomere, Telomerase, Catalytic Domain, Haploinsufficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.